Table 3.
Adjusted odds ratio (95% confidence interval) of the multivariate regression analyses of post-COVID memory loss at T2 and T3 follow-up periods.
| T2 (13.2 months) | T3 (18.3 months) | |
|---|---|---|
| Age | 1.010 (0.993, 1.026) | 0.987 (0.958, 1.016) |
| Female sex | 0.951 (0.597, 1.515) | 1.000 (0.633, 1.578) |
| Weight | 1.008 (0.977, 1.039) | 0.992 (0.976, 1.008) |
| Medical co-morbidities | ||
| Hypertension | 1.309 (0.821, 2.089) | 1.100 (0.697, 1.578) |
| Diabetes | 0.973 (0.531, 1.784) | 0.690 (0.368, 1.293) |
| Cardiovascular diseases | 1.105 (0.605, 2.016) | 1.083 (0.607, 1.935) |
| Asthma | 0.776 (0.368, 1.638) | 0.664 (0.313, 1.409) |
| Obesity | 1.849 (0.656, 5.210) | 1.048 (0.573, 1.919) |
| Chronic obstructive pulmonary disease | 1.067 (0.376, 3.030) | 0.573 (0.185, 1.771) |
| Rheumatological diseases | 0.975 (0.193, 4.934) | 1.044 (0.627, 1.737) |
| Symptoms at hospital admission | ||
| Dyspnea | 1.003 (0.628, 1.602) | 1.193 (0.755, 1.884) |
| Cough | 1.238 (0.777, 1.972) | 1.187 (0.775, 1.865) |
| Myalgias | 0.937 (0.588, 1.494) | 0.898 (0.566, 1.427) |
| Headache | 1.255 (0.742, 2.122) | 0.908 (0.516, 1.598) |
| Diarrhea | 1.013 (0.537, 1.911) | 1.373 (0.736, 2.561) |
| Anosmia | 0.846 (0.381, 1.879) | 0.871 (0.382, 1.986) |
| Ageusia | 1.754 (0.836, 3.677) | 1.233 (0.589, 2.584) |
| Throat pain | 1.313 (0.576, 2.993) | 1.733 (0.793, 3.788) |
| Vomiting | 1.309 (0.449, 3.816) | 1.563 (0.583, 4.188) |
| Dizziness | 0.833 (0.320, 2.170) | 1.957 (0.841, 4.554) |
| Days at the hospital | 0.959 (0.522, 1.176) | 0.868 (0.462, 1.631) |
| Intensive care unit (ICU) admission | 0.825 (0.441, 1.540) | 0.889 (0.484, 1.630) |
| Memory loss at T1 (8.4 months) | 8.054 (5.196, 12.484)# | 6.317 (4.109, 9.713)# |
#p < 0.001.